Max Healthcare Institute Limited (MAXHEALTH) — Financial Results | 6 February 2025

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare Institute reported ₹2,381 crores revenue, up 34% YoY, with EBITDA margin at 27.3% and net debt at Rs.1,608 crores. The company achieved EBITDA breakeven at its new Dwarka hospital within six months and plans asset-light expansions in Thane (500 beds, commissioning 2028) and Mohali (400 beds). Oncology revenue growth and fee revisions are driving profitability, while IRDAI's senior citizen insurance cap supports pricing stability. Institutional patient mix and international growth are expanding revenue streams, with targeted ROCE of 20-25% within four years.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day